Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer

Inclusion Criteria:

1. Age: ≥18 years old, no gender limit;
2. Inoperable locally advanced or metastatic pancreatic cancer patients (except isletcell carcinoma) diagnosed by pathology or histology;
3. The patient has not undergone standard systemic treatment in the past, or more thanhalf a year after the end of postoperative treatment.For those who have undergonemajor surgery or radiotherapy, the interval must be more than 4 weeks and theirmetastases have not received any local treatment including radiotherapy, chemotherapy,surgical treatment, etc.;
4. At least one measurable lesion (CT scan of tumor lesions with long diameter ≥ 10 mm,CT scan of lymph node lesions with short diameter ≥ 15 mm, and scan thickness notgreater than 6 mm);
5. The main organs are functioning normally, that is, they meet the followingstandards:Routine blood examination: Hb≥90g/L (no blood transfusion within 14days);ANC ≥1.5×109/L;PLT ≥100×109/L;Biochemical examination: ALB≥29 g/L (without ALBin 14 days), TBIL <1.5 times the upper limit of normal (ULN);ALT and AST≤3ULN,accompanied by liver metastasis, then ALT and AST<5×ULN;Cr ≤1.5×ULN or creatinineclearance rate ≥60ml/min;
6. The subject voluntarily joined the study and signed an informed consent form, withgood compliance and cooperation with follow-up

Exclusion Criteria:

1. Pregnant or lactating women;
2. Patients suffering from other malignant tumors in the past or at the same time, exceptfor cured skin basal cell carcinoma and cervical carcinoma in situ;
3. Those who have been confirmed to be allergic to the test drug albumin-bound paclitaxeland gemcitabine or its excipients.
4. The patient has clinically significant ascites;
5. Those who have experienced arterial/venous thrombosis within six months, such ascerebrovascular accidents (including temporary ischemic attacks), deep vein thrombosisand pulmonary embolism;
6. Patients with active hepatitis B or C;
7. Doctors think it is not suitable for inclusion.